THE STUDY OF DRUG SENSITIVITY MYCOBACTERIUM FORTUITUM COMPLEX
Abstract
The drug sensitivity of 258 strains of rapidly growing mycobacteria of the fortuitum coMPlex was studied by broth microdilution method to 15 chemotherapeutic agents (Sensititre RAPMyco). It was established that M. fortuitum and M. peregrinum, which are included in the coMPlex, have similar sensitivity / resistance to the studied drugs. At the same time, they remain sensitive to a number of chemotherapy drugs, and in some cases, with a large number of resistant cultures, there are quite a significant number of strains with «intermediate» sensitivity, which creates a «reserve» for chemotherapy.
About the Authors
M. V. Makarova
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
S. G. Safonova
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
Yu. D. Mikhaylova
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
L. D. Guntupova
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
A. O. Chizhova
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
V. I. Litvinov
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
References
1. Литвинов В.И., Мороз А.М. (титул. ред.) Лабораторные исследования при туберкулезе. – М.: МНПЦБТ, 2013. – 342 с.
2. Литвинов В.И., Богородская Е.М., Борисов С.Е. Нетуберкулезные микобактерии, микобактериозы. – М.: МНПЦБТ, 2014. – 254 с.
3. Оттен Т.Ф., Васильев А.В. Микобактериоз. – СПб.: Мед. пресса, 2005. – 224 с.
4. Abuali M., Katariwala R., LaBombardi V. A coMParison of the Sensititre® MYCOTB panel and the agar proportion method for the susceptibility testing of Mycobacterium tuberculosis // Eur. J. Clin. Microbiol. Infect. Dis. – 2011. – Vol. 31. – N. 5. – P. 835-839.
5. Babady N., Hall L., Abbenyi A. et al. Evaluation of Mycobacterium avium coMPlex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and Just-One strips // J. Clin. Microbiol. – 2010. – Vol. 48.– N. 5. – Р. 1749-1752.
6. Brown-Elliott B., Griffith D., Wallace R. Diagnosis of nontuberculous mycobacterial infections // J. Clin. Lab. Med. – 2002. – Vol. 22. – Р. 911-925.
7. Brown-Elliott B., Nash K., Wallace R. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria // Clin. Microbiol. Rev. – 2012. – Vol. 25. – N. 3. – Р. 545-582.
8. Cavusoglu C., Gurpinar T., Ecemis T. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel // New. Microbiol. – 2012. – Vol. 35. – N. 1. – P. 73-76.
9. Chazel M., Marchandin H., Keck N. et al. Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates // Ann. Clin. Microbiol. Antimicrob. – 2016. – Vol. 15. – P. 30.
10. CLSI. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard: 2nd ed. CLSI document M24-A2. – Wayne, PA: Clinical and Laboratory Standards Institute, 2011. [Электронный ресурс]. URL: https://www.clsi.org/media/1463/m24a2_saMPle.pdf. (Дата обращения 01.06.2018).
11. Griffith D., Aksamit T., Brown-Elliott B. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases // J. Respir. Crit. Care Med. – 2007. – Vol. 175. – N. 4. – Р. 367-416.
12. Griffith D. Nontuberculous mycobacterial disease research. an end to the beginning // Am. J. Respir. Crit. Care. Med. – 2015. – Vol. 192. – N. 5. – P. 535-537.
13. Hall L., Jude K. P., Clark S.L. et al. Evaluation of the Sensititre MycoTB plate for susceptibility testing of the Mycobacterium tuberculosis сoMPlex against first- and second-line agents // J. Clin.Microbiol. – 2012. – Vol. 50. – N. 11. – Р. 3732-3734.
14. Halstrom S., Price P., Thomson R. Review: Environmental mycobacteria as a cause of human infection // Int. J. Mycobacteriol. – 2015. – Vol. 4. – N. 2. – P. 81-91.
15. Heifets L. Drug susceptibility in the chemotherapy of mycobacterial infections. – CRC Press. Boca Raton Ann Arbor Boston. London, 2000. – 212 p.
16. Heifets L. Mycobacterial infections caused by nontuberculous mycobacteria // Semin. Respir. Crit. Care Med. – 2004. – Vol. 25. – N. 3. – Р. 283-295.
17. Kasperbauer S., De Groote M. The treatment of rapidly growing mycobacterial infections // Clin. Chest. Med. – 2015. – Vol. 36. – N. 1. – P. 67-78.
18. Koh W. Nontuberculous mycobacteria-overview // Microbiol. Spectr. – 2017. – Vol. 5. – N. 1. – doi: 10.1128/microbiolspec. TNMI7-0024-2016.
19. Lee S., Yoo H., Kim S. et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea // Ann. Lab. Med. – 2014. – Vol. 34. – N. 1. – P. 31-37.
20. Nie W., Duan H., Huang H. et. al. Species identification and clarithromycin susceptibility testing of 278 clinical nontuberculosis mycobacteria isolates // Biomed. Res. Int. – 2015. – Р. 506-598.
21. Pang H., Li G., Wan L. et al. In vitro drug susceptibility of 40 international reference rapidly growing mycobacteria to 20 antimicrobial agents // Int. J. Clin.Exp. Med. – 2015 (а). – Vol. 8. – N. 9. – P. 15 423-431.
22. Pang H., Li G., Zhao X. et al. Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China // Biomed. Res. Int. – 2015 (b). – 2015. – e: 419392.
23. Richter E., Andres S., Hillemann D. Current microbiological methods in the investigation of mycobacteria // Pneumologie. – 2015. – Vol. 69. – N. 5. – P. 276-281.
24. Set R., Rokade S., Agrawal S., Shastri J. Antimicrobial susceptibility testing of rapidly growing mycobacteria by microdilution - experience of a tertiary care centre // Indian. J. Med. Microbiol. – 2010. – Vol. 28. – N. 1. – P. 48-50.
25. Stout J., Koh W., Yew W. Update on pulmonary disease due to non-tuberculous mycobacteria // Int. J. Infect. Dis. – 2016. – Vol. 45. – P. 123-134.
26. Tortoli E. Clinical manifestations of nontuberculous mycobacteria infections // Clin. Microbiol. Infect. – 2009. – Vol. 15. – N. 10. – P. 906-910.
27. van Ingen J., Boeree M., van Soolingen D. et al. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria // Drug Resist. Updat. – 2012. – Vol. 15. – N. 3. – Р. 149-161.
28. van Ingen J., Kuijper E. Drug susceptibility testing of nontuberculous mycobacteria // Future Microbiol. – 2014. – Vol. 9. – N. 9. – P. 1095-1110.
29. van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease // Clin. Chest. Med. – 2015 (a). – Vol. 36. – N. 1. – P. 43-54.
30. van Ingen J. Treatment of pulmonary disease caused by non-tuberculous mycobacteria // Lancet. Respir. Med. – 2015 (b). – Vol. 3. – N. 3. – P. 179-180.
31. Velayati A., Rahideh S., Nezhad Z. et al. Nontuberculous mycobacteria in Middle East: current situation and future challenges // Int. J. Mycobacteriol. – 2015. – Vol. 4. – N. 1. – P. 7-17.
32. Wallace R., Nash D., Steele L., Steingrube V. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth // J. Clin. Microbiol. – 1986. – Vol. 24. – N. 6. – P. 976-981.
33. Woods G. Susceptibility testing for mycobacteria // Clin. Infect. Dis. – 2000. - Vol. 31. – N. 5. – P. 1209-1215.
34. Yamane N., Onaga S., Saitoh H. et al. Multicenter evaluation of a newly developed microdilution test, broth MIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria // Rinsho. Byori. – 2002. – Vol. 50. – N. 4. – P. 381-391.
35. Yano Y., Kitada S., Mori M. et al. Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan // Respiration. – 2013. – Vol. 85. – N. 4. – P. 305-311.
Review
For citations:
Makarova M.V., Safonova S.G., Mikhaylova Yu.D., Guntupova L.D., Chizhova A.O., Litvinov V.I. THE STUDY OF DRUG SENSITIVITY MYCOBACTERIUM FORTUITUM COMPLEX. Tuberculosis and socially significant diseases. 2018;(4):20-27. (In Russ.)
Views:
21
Email this article 